Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI
Bikash Panthi(The University of Texas MD Anderson Cancer Center), Gaiane M. Rauch(The University of Texas MD Anderson Cancer Center), Peng Wei(Creighton University), Anil Korkut, Jennifer K. Litton(The University of Texas MD Anderson Cancer Center), Kelly K. Hunt(The University of Texas MD Anderson Cancer Center), Jason B. White(The University of Texas MD Anderson Cancer Center), Alastair M. Thompson(Baylor College of Medicine), Frances Perez(The University of Texas MD Anderson Cancer Center), Rania M. Mohamed(The University of Texas MD Anderson Cancer Center), Jessica W. T. Leung(The University of Texas MD Anderson Cancer Center), Miral Patel(The University of Texas MD Anderson Cancer Center), Deanna L. Lane(The University of Texas MD Anderson Cancer Center), Sanaz Pashapoor(The University of Texas MD Anderson Cancer Center), Jong Bum Son(The University of Texas MD Anderson Cancer Center), Mary S. Guirguis(The University of Texas MD Anderson Cancer Center), Clinton Yam(The University of Texas MD Anderson Cancer Center), Rosalind P. Candelaria(The University of Texas MD Anderson Cancer Center), Benjamin C. Musall(Henry Ford Health System), Beatriz E. Adrada(The University of Texas MD Anderson Cancer Center), Zhan Xu(The University of Texas MD Anderson Cancer Center), Vicente Valero(The University of Texas MD Anderson Cancer Center), Wei Yang(Shanghai Jiao Tong University), Medine Böge(The University of Texas MD Anderson Cancer Center), Jingfei Ma(The University of Texas MD Anderson Cancer Center), Huiqin Chen(Soochow University), L. Pinsky(University of Houston), H. Carisa Le-Petross(The University of Texas MD Anderson Cancer Center), Lei Huo(The University of Texas MD Anderson Cancer Center), Debu Tripathy(The University of Texas MD Anderson Cancer Center), Ken‐Pin Hwang(The University of Texas MD Anderson Cancer Center)
Cited by 25
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.4k
Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
|Human Molecular Genetics|2014|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k